CPHI Korea 2026
08/2026 – 08/2026
About Company
- Legal Name: Hunan Kerey Pharmaceutical Co., Ltd.
- Registered country: China
- Address: Caixing Rd, Economic Development Zone, Xinshao County, Shaoyang • Hunan
- Established year: 2005
Description:
Originally founded in 2005 in Shaoyang City, Hunan Province as Shaoyang Kerey Chemicals, Hunan Kerey Pharmaceutical specializes in developing steroid hormone materials from stigmasterol as a starting material, along with plant-origin cholesterol and cholic acid materials. Listed on the NEEQ in 2015 and inspected by the US FDA in June 2017, the company built a multifunction workshop for CMO business in 2017, operating five modern workshops that follow GMP regulations to meet USP, EP and BP standards, with strong R&D capabilities expanding beyond steroids into other fine chemicals.
Business Activities
Active Pharmaceutical Ingredients (APIs)
ExporterAPI Manufacturer
Pharma Chemicals
API Manufacturer
Biopharmaceutical Products
API Manufacturer
Innovator APIs
API Manufacturer
Sales Markets
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
Key Products/Services
- Active Pharmaceutical Ingredients (APIs): Vitamin D3, 17α- Hydroxyprogesterone, 17alpha-hydroxyprogesterone, Guggulsterones
- Pharma Chemicals: 17a -hydroxy progesterone acetate, Finasteride intermediate, 25-Hydroxy-7-Dehydrocholesterol, API & INTERMEDIATES, 17α-Hydroxy progesterone acetate, Dutasteride API and intermediates
- Innovator APIs: Progesterone
Our Products & Services
Proofs
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment